SEC Form 4 · accession 0001209191-16-125718
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Margaret G McGlynn
Director
Period of report
Jun 1, 2016
Accepted (ET)
Jun 3, 2016 · 5:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2016 | A | 2,941 | $0.01 | A | 4,029 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $93.51 | Jun 1, 2016 | A | 7,073 | A | — | May 31, 2026 | Common Stock | 7,073 | 7,073 | D |
Explanation of responses
- F1Restricted stock unit award that vests on the first anniversary of the grant date.
- F2Fully vested.